Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss. The Company develops a technology which will help to replace lost hair cells by cellular regeneration originating from supporting cells. It works on drugs for local application, which will restore hearing in patients who have lost their hearing ability due to various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, this therapy will have the potential to treat the age-related decrease in hearing capacity.